| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |